Private Equity
Prime Movers Lab has raised $15.49 million for its inaugural fund, according to an SEC filing. Jackson, Wyoming-based Prime Movers Lab invests in physics-powered startups founded by Prime Movers.
1 min read · 27 November 2018
Washington, D.C.-based MPOWER Financing, a student loan provider to promising international students, has raised $110 million in funding. Gray Matters Capital and Community Investment Management led the round.
3 min read · 27 November 2018
Evolv Technology, a creator of a people-screening system that detects weapons and bombs, has named David Orfao and Alan Cohen to its board of directors. Orfao is a co-founder of General Catalyst while Cohen was recently a chief commercial officer at Illumio.
3 min read · 27 November 2018
Arc Labs has raised $32 million for an early-stage credit fund. Based in San Francisco, Arc is focused on providing credit solutions to venture-backed startups. Arc Labs is backed by Bracket Capital.
2 min read · 27 November 2018
Upward Labs has secured up to $3.9 million from Connecticut Innovations. Based in the Hartford, Connecticut area, Upward Labs is an incubator focused on early-stage companies and developing pilot programs in the smart building and aged care market segments.
1 min read · 27 November 2018
Square 1 Bank, a unit of Pacific Western Bank, has provided a $5 million credit facility to South San Francisco-based Zenflow, a urologic medical device company. The financing will be used to support Zenflow's growth initiatives. Zenflow's backers include F-Prime Capital Partners, Invus Opportunities, Medical Technology Venture Partners, Y Combinator and the Stanford-StartX Fund.
3 min read · 27 November 2018
Antios Therapeutics Inc, a biopharmaceutical company, has secured $25 million in Series A financing. Lumira Ventures and Domain Associates led the round.
1 min read · 27 November 2018
INKEF Capital, a Dutch venture firm, has named Roel Bulthuis as managing director and head of healthcare team. Previously, he worked at M Ventures.
3 min read · 27 November 2018
The Ireland Strategic Investment Fund, WuXi NextCODE and Genomics Medicine Ireland have launched a $400 million investment program aimed at making Ireland a hub for genomics research and development of new disease treatments and cures. The other investors in this initiative include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital.
5 min read · 27 November 2018
New York City-based Rgenix, Inc, a developer of small molecule and antibody cancer therapeutics, has named Dr. Peter Van Vlasselaer to its board of directors. Recently, he was the president and CEO of ARMO Biosciences. Rgenix's backers include Novo A/S, Sofinnova Partners, Lepu Medical, Oceanpine Capital, WuXi AppTec’s Corporate Venture Fund, Alexandria Venture Investments and the Partnership Fund for New York City’s Innovate NY Fund.
3 min read · 27 November 2018
